Literature DB >> 16571658

A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing.

Theresa M Rowe1, Mark Rizzi, Keiko Hirose, Gregory A Peters, Ganes C Sen.   

Abstract

To determine the physiological functions of the mammalian double-stranded RNA-binding protein PACT, the single-copy mouse Pact gene was disrupted and expression of the protein was completely ablated. The most notable phenotypes of the Pact(-/-) mouse were reduced size and severe microtia. As a result of the congenital abnormality of both outer and middle ears, these mice were hearing impaired. In situ hybridization revealed that PACT mRNA was expressed in specific regions of all three parts of the ear in adult and embryonic wild-type mice. Our study demonstrated an essential role of PACT in mammalian ear development and produced the first animal model for studying human microtia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571658      PMCID: PMC1458657          DOI: 10.1073/pnas.0601287103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Modular structure of PACT: distinct domains for binding and activating PKR.

Authors:  G A Peters; R Hartmann; J Qin; G C Sen
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

3.  Physiological non-equivalence of the two isoforms of angiotensin-converting enzyme.

Authors:  S P Kessler; T M Rowe; J B Gomos; P M Kessler; G C Sen
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

4.  Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis.

Authors:  Q Wang; J Khillan; P Gadue; K Nishikura
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

5.  Organizations and promoter analyses of the human and the mouse genes for PACT, the protein-activator of the interferon-induced protein kinase, PKR.

Authors:  T M Rowe; G C Sen
Journal:  Gene       Date:  2001-08-08       Impact factor: 3.688

6.  Identification of two RNA-binding proteins associated with human telomerase RNA.

Authors:  S Le; R Sternglanz; C W Greider
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

7.  Human telomerase RNA-protein interactions.

Authors:  F Bachand; I Triki; C Autexier
Journal:  Nucleic Acids Res       Date:  2001-08-15       Impact factor: 16.971

8.  Mice deficient for spermatid perinuclear RNA-binding protein show neurologic, spermatogenic, and sperm morphological abnormalities.

Authors:  A Pires-daSilva; K Nayernia; W Engel; M Torres; A Stoykova; K Chowdhury; P Gruss
Journal:  Dev Biol       Date:  2001-05-15       Impact factor: 3.582

Review 9.  Clinical features, treatment and genetic background of Treacher Collins syndrome.

Authors:  Bozena Marszałek; Piotr Wójcicki; Kazimierz Kobus; Wiesław H Trzeciak
Journal:  J Appl Genet       Date:  2002       Impact factor: 3.240

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  32 in total

Review 1.  Structural and biochemical advances in mammalian RNAi.

Authors:  Robert E Collins; Xiaodong Cheng
Journal:  J Cell Biochem       Date:  2006-12-01       Impact factor: 4.429

2.  Antagonistic and stimulative roles of ADAR1 in RNA silencing.

Authors:  Kazuko Nishikura; Masayuki Sakurai; Kantaro Ariyoshi; Hiromitsu Ota
Journal:  RNA Biol       Date:  2013-07-30       Impact factor: 4.652

3.  ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing.

Authors:  Hiromitsu Ota; Masayuki Sakurai; Ravi Gupta; Louis Valente; Bjorn-Erik Wulff; Kentaro Ariyoshi; Hisashi Iizasa; Ramana V Davuluri; Kazuko Nishikura
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

Review 4.  The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer.

Authors:  Sylvanne M Daniels; Anne Gatignol
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

5.  Arenaviral Nucleoproteins Suppress PACT-Induced Augmentation of RIG-I Function To Inhibit Type I Interferon Production.

Authors:  Yuying Liang; Hinh Ly; Junjie Shao; Qinfeng Huang; Xiaoying Liu; Da Di
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

6.  dsRNA binding protein PACT/RAX in gene silencing, development and diseases.

Authors:  Yue Yong; Jia Luo; Zun-Ji Ke
Journal:  Front Biol (Beijing)       Date:  2014-10

7.  Dicer partner proteins tune the length of mature miRNAs in flies and mammals.

Authors:  Ryuya Fukunaga; Bo W Han; Jui-Hung Hung; Jia Xu; Zhiping Weng; Phillip D Zamore
Journal:  Cell       Date:  2012-10-11       Impact factor: 41.582

8.  Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies.

Authors:  Justin M Pare; Nasser Tahbaz; Joaquín López-Orozco; Paul LaPointe; Paul Lasko; Tom C Hobman
Journal:  Mol Biol Cell       Date:  2009-05-20       Impact factor: 4.138

9.  The protein activator of protein kinase R, PACT/RAX, negatively regulates protein kinase R during mouse anterior pituitary development.

Authors:  Benjamin K Dickerman; Christine L White; Patricia M Kessler; Anthony J Sadler; Bryan R G Williams; Ganes C Sen
Journal:  FEBS J       Date:  2015-10-26       Impact factor: 5.542

10.  TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress.

Authors:  Aïcha Daher; Ghislaine Laraki; Madhurima Singh; Carlos E Melendez-Peña; Sylvie Bannwarth; Antoine H F M Peters; Eliane F Meurs; Robert E Braun; Rekha C Patel; Anne Gatignol
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.